Newsroom

Articles
Mini-Lab

Mini-Lab presentation at ECCMID 2022 in Lisbon

MSF and the Mini-Lab team were present at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from 23 to 26 April 2022.

Read more
Articles
Mini-Lab

The Mini-Lab is deployed in Aweil, South Sudan in April 2022

The Mini-Lab has been deployed in Aweil, South Sudan in April 2022.

Read more
Articles
Mini-Lab

Launch of the internal deployment plan

Mini-Lab is now ready to be deployed within the MSF Movement.

Read more
Articles
Mini-Lab

Mini-Lab collaborates with WHONET

MSF is pleased to announce the partnership between MSF and WHONET to integrate WHONET's expertise into the Laboratory Information Management System (Mini-LIMS) to facilitate the interpretation of antibiotic susceptibility tests (AST)

Read more
Articles
Mini-Lab

Deployment of the second Mini-LAB pilot on the field in Bangui (Central African Republic)

Read more

Headline

MSF Foundation in Video

  • Officially launching of Antibiogo : Webinar
    Vidéos

    Officially launching of Antibiogo : Webinar

  • AdreUne
    Vidéos

    Report from Adre in Chad, where MSF Foundation teams explore the needs for pediatric rehabilitation.

  • YemenUne_en
    Vidéos

    Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites.

More articles

News

  • Articles
    Antibiogo

    Antibiogo: facts and impacts in the fight against antimicrobial resistance

    The World Health Organization's Global AMR Awareness Week is a worldwide campaign to raise awareness and understanding of the problem of antimicrobial resistance. To mark the occasion, here is a series of infographics to help you better understand the hope that Antibiogo, a new diagnostic tool holds for combating this threat on public health.

    Read more
More articles

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
More articles

Press Review

More articles
No news for now.